Janssen and GSK provide keynote addresses at Controlled Release Delivery 2017

The two day conference will provide attendees with 5+ hours of networking time, an exclusive post-conference workshop and 16 thought provoking presentations covering the topics of; innovations in drug delivery; nanoparticles, nanomedicine & QbD, CNS drug delivery and therapeutic applications.

Hear from Merck, Novartis, Janssen, Actelion, GSK, Boehringer Ingelheim and many more as they evaluate: generic drug development, biopharmaceutical approaches, oral bioavailability and parenteral drug delivery.

Keynote addresses for Controlled Release Delivery 2017:

René Holm, Head and Scientific Director, Liquids & Parenterals, from Janssen will be presenting on ‘Lipid suspensions – how, when and with what?’ René will discuss:

• What is a lipid based suspension and how could it look from a commercialisation perspective?
• When can lipid based suspensions be used to improve the oral bioavailability?
• How large a proportion of the compound needs to be solubilised in the lipid phase?
• What excipients to use for lipid based formulation?

Mark Wilson, Director, Technology Licensing, PTS from GlaxoSmithKline will be speaking on ‘The development and commercialisation of drug delivery systems: Challenges and opportunities’, where he will provide attendees with information on the following:

• GSK’s experiences in developing technologies
• The collaborative “open innovation” approach
• Commercialisation challenges – finding the breakthrough application
• Examples of successful development and exploitation projects
• GSK’s approach to working with other organisations

A full speaker line-up and detailed conference agenda is available to download online at www.controlledreleasedelivery.com/dtr . For those looking to attend, there is currently a £100 discount available which expires on 28^th February 2017.

Controlled Release Delivery

Strengthening innovation and overcoming the challenging regulatory landscape
3^rd & 4^th April 2017
London, UK
Sponsored by: Avanti Polar Lipids, Buchi, Data Detection Technologies, Precision NanoSystems and Sirius Analytical
www.controlledreleasedelivery.com/dtr    

Contact Information:

For all media enquiries contact Zoe Gale on Tel: +44 (0)20 7827 6032 / Email: [email protected]

To register for the conference, visit www.controlledreleasedelivery.com/dtr or contact Ameenah Begum for group bookings on Tel: +44 (0)20 7827 6166 / Email: [email protected]

To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: [email protected]